ALLOTTA, Alberto
 Distribuzione geografica
Continente #
NA - Nord America 235
AS - Asia 70
EU - Europa 58
SA - Sud America 8
Totale 371
Nazione #
US - Stati Uniti d'America 234
IT - Italia 28
SG - Singapore 25
CN - Cina 22
RU - Federazione Russa 12
HK - Hong Kong 9
BR - Brasile 7
VN - Vietnam 7
DE - Germania 4
BE - Belgio 3
FI - Finlandia 3
PL - Polonia 3
GB - Regno Unito 2
IN - India 2
AR - Argentina 1
BD - Bangladesh 1
CA - Canada 1
GE - Georgia 1
ID - Indonesia 1
MY - Malesia 1
NL - Olanda 1
SE - Svezia 1
TR - Turchia 1
UA - Ucraina 1
Totale 371
Città #
Fairfield 35
Woodbridge 19
Singapore 18
Ann Arbor 17
Cambridge 17
Houston 17
Ashburn 16
Seattle 14
Chandler 12
Palermo 12
Wilmington 12
Santa Clara 10
Hong Kong 9
Hanoi 5
Altamura 4
Beijing 4
Los Angeles 4
Moscow 4
San Diego 4
Brussels 3
Columbus 3
Dearborn 3
Medford 3
New York 3
Shenyang 3
Zgierz 3
Atlanta 2
Buffalo 2
Chicago 2
Hebei 2
Lawrence 2
Princeton 2
Taizhou 2
Vasanello 2
Amsterdam 1
Barracão 1
Batam 1
Boston 1
Can Tho 1
Cerro Radal 1
Chennai 1
Dallas 1
Frankfurt am Main 1
Guarulhos 1
Hefei 1
Helsinki 1
Ilhéus 1
Jarinu 1
Jiaxing 1
Jinan 1
Kuala Lumpur 1
Kumar 1
Ludwigshafen am Rhein 1
Monreale 1
Mossoró 1
Nanchang 1
Ningbo 1
Nuremberg 1
Ouro Branco 1
Phoenix 1
Pio XII 1
Rome 1
San Jose 1
Tbilisi 1
Thái Bình 1
Toronto 1
Tulsa 1
Vynohradiv 1
Wandsworth 1
Zhengzhou 1
Totale 306
Nome #
Omalizumab for the treatment of chronic spontaneous urticaria in clinical practice 163
Cardiovascular Events in Rheumatoid Arthritis - Time to See beyond Articular Involvement in "real World" Clinical Practice: Comment on the Article by Mackey et al 162
Effect of Semaglutide on Subclinical Atherosclerosis and Cardiometabolic Compensation: A Real-World Study in Patients with Type 2 Diabetes 62
Totale 387
Categoria #
all - tutte 1.461
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1.461


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202124 0 0 0 0 0 3 0 1 6 9 4 1
2021/202226 2 5 2 1 0 0 3 1 3 4 2 3
2022/202328 3 10 1 4 6 1 0 0 0 0 1 2
2023/202414 0 2 0 2 1 6 1 1 0 0 0 1
2024/202564 1 7 13 3 3 1 3 6 1 6 5 15
2025/202679 11 1 16 19 15 17 0 0 0 0 0 0
Totale 387